Inappropriate Ordering, Prescribing or Dispensing of Medications to Treat COVID-19

This joint statement was issued by the AMA, APhA, and ASHP to address the inappropriate use of medications to treat COVID-19. This statement reminds physicians, pharmacists, and health systems of their role as stewards of health care resources during this pandemic.

It goes on to discourage prophylactic use of medications such as chloroquine, hydroxychloroquine, and azithromycin to prevent COVID-19 and cautions that no treatment has been approved by the FDA for COVID-19. Through this statement, the organizations support direct prescribing of medications for a specific medical purpose.

Read Statement

Need More COVID-19 Resources?

Visit Toolkit

Content Related to this Article


Fulfill Your MATE Act Training Requirements with Free Courses

Complete your MATE Act training requirements before renewing your DEA license with these free courses.

Learn More

Claim Study

Patient Care At Risk: Preventing Medication Errors

This medication error case study discusses a tragic claim involving a newborn infant.

Learn More


How the RaDonda Vaught Case Could Impact Healthcare

Adverse medication events pose a significant risk to patients, healthcare staff, and the healthcare systems. However, foc...

Learn More